Clinical Trial Update: Losartan in Decompensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating losartan in decompensated heart failure has completed. The sponsor listed is InCor Heart Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: InCor Heart Institute | Conditions: Congestive Heart Failure, Low Cardiac Output | Phase 4 | Status: COMPLETED